Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (151-160 of 387) with videos related to

Pageof 39
Sort By:
BMC Medical Genomics|October 14, 2015
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathwaysDavid A Ewald, Dana Malajian, James G Krueger, et al.
Cell Reports|August 9, 2025
A basophil-fibroblast pro-inflammatory axis fuels type 2 skin inflammationIchiro Imanishi, Raman Gill, Alexis Wilder, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 14, 2023
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient SurveyJonathan I Silverberg, Jennifer A Mohawk, Joshua Cirulli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2020
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized studyJonathan I Silverberg, Emma Guttman-Yassky, Melinda Gooderham, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology|March 11, 2011
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesMayte Suárez-Fariñas, Suzanne J Tintle, Avner Shemer, et al.
The Journal of Allergy and Clinical Immunology|May 15, 2009
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cellsKristine E Nograles, Lisa C Zaba, Avner Shemer, et al.
Cancer Immunology Research|June 19, 2014
IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarizationHanako Ohmatsu, Daniel Humme, Nicholas Gulati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
Arginase1 Deficiency in Monocytes/Macrophages Upregulates Inducible Nitric Oxide Synthase To Promote Cutaneous Contact HypersensitivityJutamas Suwanpradid, Michael Shih, Lauren Pontius, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Clinical Relevance of Skin Pain in Atopic DermatitisSonja Ständer, Eric L Simpson, Emma Guttman-Yassky, et al.
Pageof 39

Showing results (151-160 of 387) with videos related to

Sort By:
Pageof 39
BMC Medical Genomics|October 14, 2015
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathwaysDavid A Ewald, Dana Malajian, James G Krueger, et al.
Cell Reports|August 9, 2025
A basophil-fibroblast pro-inflammatory axis fuels type 2 skin inflammationIchiro Imanishi, Raman Gill, Alexis Wilder, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 14, 2023
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient SurveyJonathan I Silverberg, Jennifer A Mohawk, Joshua Cirulli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2020
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized studyJonathan I Silverberg, Emma Guttman-Yassky, Melinda Gooderham, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology|March 11, 2011
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesMayte Suárez-Fariñas, Suzanne J Tintle, Avner Shemer, et al.
The Journal of Allergy and Clinical Immunology|May 15, 2009
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cellsKristine E Nograles, Lisa C Zaba, Avner Shemer, et al.
Cancer Immunology Research|June 19, 2014
IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarizationHanako Ohmatsu, Daniel Humme, Nicholas Gulati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
Arginase1 Deficiency in Monocytes/Macrophages Upregulates Inducible Nitric Oxide Synthase To Promote Cutaneous Contact HypersensitivityJutamas Suwanpradid, Michael Shih, Lauren Pontius, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Clinical Relevance of Skin Pain in Atopic DermatitisSonja Ständer, Eric L Simpson, Emma Guttman-Yassky, et al.
Pageof 39